Interaction of superoxide dismutase with the glycine zipper regions of β-amyloid peptides: Is there an implication towards Alzheimer's disease and oxidative stress

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 28, Issue 4, 2013, Pages 727-733

  Oyatsi, F ^a   Whiteley, C G ^a  

^a RHODES UNIVERSITY   (South Africa)

Author keywords

amyloid peptide; Alzheimer's disease; Enzyme kinetics; Glycine zipper; Inhibition; Oxidative stress; Superoxide dismutase

Indexed keywords

2 DIETHYLAMINOETHANOL; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[25-37]; AMYLOID BETA PROTEIN[29-33]; GLYCINE; SEPHAROSE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; DISSOCIATION CONSTANT; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; ION EXCHANGE CHROMATOGRAPHY; MOLECULAR WEIGHT; NONHUMAN; OXIDATIVE STRESS; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION; PROTEIN QUATERNARY STRUCTURE; QUANTUM YIELD;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CATTLE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLYCINE; KINETICS; OXIDATIVE STRESS; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP; SUPEROXIDE DISMUTASE;

EID: 84879797762     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.3109/14756366.2012.680063     Document Type: Article

References (24)

1. Hardy J. A hundred years of Alzheimer's disease research. Neuron 2006;52:3-13.
2. Selkoe DJ. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem 1996;271:18295-18298.
3. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ. Amyloidbeta oligomers: their production, toxicity and therapeutic inhibition. Biochem Soc Trans 2002;30:552-557.
4. Kim S, Jeon TJ, Oberai A, Yang D, Schmidt JJ, Bowie JU. Transmembrane glycine zippers: physiological and pathological roles in membrane proteins. Proc Natl Acad Sci USA 2005;102:14278-14283.
5. Gralle M, Ferreira ST. Structure and functions of the human amyloid precursor protein: the whole is more than the sum of its parts. Prog Neurobiol 2007;82:11-32.
6. Gouras GK, Almeida CG, Takahashi RH. Intraneuronal Abeta accumulation and origin of plaques in Alzheimer's disease. Neurobiol Aging 2005;26:1235-1244.
7. Jarrett JT, Lansbury PT Jr. Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie? Cell 1993;73:1055-1058.
8. Soto C, Brañes MC, Alvarez J, Inestrosa NC. Structural determinants of the Alzheimer's amyloid beta-peptide. J Neurochem 1994;63:1191-1198.
9. Findeis MA. The role of amyloid beta peptide 42 in Alzheimer's disease. Pharmacol Ther 2007;116:266-286.
10. Soto C, Castano E, Frangione B, Inestrosa NC. The α-helical to β-strand transition in the N-terminal fragment of the amyloid β-peptide modulates amyloid formation. J Biol Chem 1995;266:4025-4028.
11. Poulos TL, Li H, Shimizu H, Flinspach M, Jamal J, Yang W, Xian M, Cai T, Zhong WE, Jia Q, Wang PG. The novel binding mode of N-Alkyl-N'-hydroxyguanidine to neuronal nitric oxide synthase provides mechanistic insights into NO biosynthesis. Biochemistry 2002;41:3868-13875.
12. Padayachee ER, Whiteley CG. Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease. Biochim Biophys Acta 2011;1810:1136-1140.
13. Padayachee E, Ngqwala NP, Whiteley CG. Association of β-amyloid peptide fragments with neuronal nitric oxide synthase: Implications in the etiology of Alzheimers disease. Enz Inhib Med Chem 2011 doi: 10.3109/14756366.2011.590805
14. Mohlake P, Whiteley CG. Arginine metabolising enzymes as therapeutic tools for Alzheimer's disease: peptidyl arginine deiminase catalyses fibrillogenesis of beta-amyloid peptides. Mol Neurobiol 2010;41:149-158.
15. Butterfield DA, Reed TT, Perluigi M, De Marco C, Coccia R, Keller JN et al. Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease. Brain Res 2007;1148:243-248.
16. Calabrese V, Mancuso C, Calvani M, Rizzarelli E, Butterfield DA, Stella AM. Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat Rev Neurosci 2007;8:766-775.
17. Celsi F, Ferri A, Casciati A, D'Ambrosi N, Rotilio G, Costa A et al. Overexpression of superoxide dismutase 1 protects against betaamyloid peptide toxicity: effect of estrogen and copper chelators. Neurochem Int 2004;44:25-33.
18. Wang J, Xiong S, Xie C, Markesbery WR, Lovell MA. Increased oxidative damage in nuclear and mitochondrial DNA in Alzheimer's disease. J Neurochem 2005;93:953-962.
19. McCord JM, Fridovich I. Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem 1969;244:6049-6055.
20. Carloni P, Blichl PE, Parrinello M. Electronic structure of the Cu-Zn superoxide dismutase active site and its interactions with the substrate. J Phys Chem 1995;99:1338-1348.
21. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
22. Barra D, Schinina ME, Simmaco M, Bannister JV, Bannister WH, Rotilio G et al. The primary structure of human liver manganese superoxide dismutase. J Biol Chem 1984;259:12595-12601.
23. Anantharaman M, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK et al. Beta-amyloid mediated nitration of manganese superoxide dismutase: implication for oxidative stress in a APPNLH/NLH X PS-1P264L/P264L double knock-in mouse model of Alzheimer's disease. Am J Pathol 2006;168:1608-1618.
24. Lovell MA, Robertson JD, Teesdale WJ, Campbell JL, Markesbery WR. Copper, iron and zinc in Alzheimer's disease senile plaques. J Neurol Sci 1998;158:47-52.